Category: Clinical Obstetrics
Poster Session I
To establish the diagnostic test accuracy of cervicovaginal interleukin-6 concentration in the detection of intraamniotic inflammation, in women with preterm prelabor rupture of membranes (PPROM) at less than 37 weeks of gestational age.
Study Design:
A systematic literature search was undertaken using Embase, SCOPUS, PubMed, and the Cochrane library from their inception to Feb 2022. Prospective and retrospective studies evaluating cervicovaginal interleukin-6 (IL-6) concentrations, in women diagnosed with PPROM at less than 37weeks of gestation, were included. Cervicovaginal IL-6 concentration was assessed as the index test for the prediction of intraamniotic inflammation. The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) was independently used by two reviewers to assess the quality of the studies. Forest plots for sensitivity and specificity with 95% CIs and hierarchical summary receiver operating characteristic curves were constructed; quantitative data synthesis was performed using random-effects models. Diagnostic odds ratios were calculated to measure the global effectiveness of the diagnostic test. Heterogeneity was assessed using Cochran’s Q statistic, with p < 0.10 denoting heterogeneity.
Results:
Eighteen studies were retained for qualitative analysis, 14 were included in the meta-analysis. The study population included 1,655 women diagnosed with PPROM. According to the QUADAS-2 tool, all included studies were of poor quality. The area under the curve (AUC) for the diagnosis of intraamniotic inflammation and/or infection by cervicovaginal IL-6 was 0.838 ± 0.035 (figure 1). Figure 2 shows the pooled diagnostic odds ratio of cervicovaginal IL-6 was found to be 10.74 (95% CI 5.45, 21.17). Based on the Cochran’s Q value of 88.03 (p = 0.00), a high degree of heterogeneity exists across studies.
Conclusion:
Cervicovaginal IL-6 has a DOR of 10.74 (95% CI 5.45, 21.17) in the detection of intrauterine inflammation/infection. Based on our results, cervicovaginal IL-6 seems to have a good diagnostic accuracy in the detection of intraamniotic inflammation/infection in women with PPROM.
Daniela Gomez, MD, MS (she/her/hers)
Perinatologist
Scripps Clinic
San Diego, California, United States
Kendra M. Gray, DO
MFM Fellow
University of Arizona
Scottsdale, Arizona, United States
Curtis Cook, MD
Dignity Health Medical Group
Chandler, Arizona, United States